Cytokines in clinical cancer therapy Journal Article


Author: Oettgen, H. F.
Article Title: Cytokines in clinical cancer therapy
Abstract: Cytokines have been of much interest in clinical cancer therapy research over the past decade. One important advance during the past year has been the clear demonstration, in large prospective randomized studies, that granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor reduce the neutropenia-related morbidity of cancer therapy. © 1991.
Keywords: neutropenia; review; antineoplastic agents; chemotherapy; neoplasms; dacarbazine; interleukin 2; melanoma; erythropoietin; anemia; bone marrow; bone marrow suppression; morbidity; granulocyte macrophage colony stimulating factor; inflammation; in vitro study; tumor regression; cancer therapy; cytokine; cytokines; gamma interferon; transforming growth factor; hematopoiesis; receptor; immunity; monocyte; macrophage; bone marrow transplantation; cell adhesion; granulocyte colony stimulating factor; beta interferon; granulocyte; interleukins; interleukin 1; drug evaluation; biological response modifiers; interferons; cancer; human; hematopoietic cell growth factors
Journal Title: Current Opinion in Immunology
Volume: 3
Issue: 5
ISSN: 0952-7915
Publisher: Elsevier Inc.  
Date Published: 1991-10-01
Start Page: 699
End Page: 705
Language: English
DOI: 10.1016/0952-7915(91)90099-m
PUBMED: 1721823
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 27 September 2019 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Herbert F Oettgen
    130 Oettgen